C 17 (Cefprozil 500 mg)
Pill imprint C 17 has been identified as Cefprozil 500 mg.
Cefprozil is used in the treatment of bladder infection; bronchitis; skin or soft tissue infection; otitis media; sinusitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefprozil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- C 17
- Strength:
- 500 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0069
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
magnesium stearate
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
shellac
ferrosoferric oxide
propylene glycol
ammonia
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16714-0399 | NorthStar Rx LLC |
Note: Inactive ingredients may vary.
More about cefprozil
Consumer resources
- Other brands: Cefzil
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
